Description
Ipamorelin is a pentapeptide classified as a selective growth hormone secretagogue, studied for its high-affinity agonism at the ghrelin/growth hormone secretagogue receptor (GHS-R1a) on pituitary somatotrophs.
In laboratory research, Ipamorelin is notable for its selectivity: unlike earlier-generation secretagogues, it is studied for producing growth hormone receptor activation with minimal measurable effect on cortisol, prolactin, or ACTH secretion, making it a useful tool for isolating GH-specific signaling pathways.
Researchers frequently use Ipamorelin in comparative studies against other growth hormone releasing peptides (GHRPs) to examine differences in receptor selectivity, downstream signaling specificity, and pulsatile secretion dynamics.
It is also studied in combination protocols alongside GHRH analogs, where the two peptide classes are examined for their complementary mechanisms of action on the somatotropic axis.
Ipamorelin’s well-characterized receptor profile and reproducible behavior in experimental systems make it a frequently cited compound in peptide pharmacology and endocrine signaling research.
Reviews
There are no reviews yet.